RACHAEL DAUME: Open Payments
NPI 1366214199 · JACKSON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$839 in 34 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $214 · 2025 $839
Food & beverage: $839
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $325 |
| Amgen Inc. | 9 | $228 |
| GlaxoSmithKline, LLC. | 5 | $191 |
| Novo Nordisk Inc | 4 | $75 |
| Phathom Pharmaceuticals, Inc. | 2 | $20 |
Products named: VRAYLAR, REPATHA, PENMENVY, UBRELVY, Ozempic, QULIPTA, OTEZLA, SHINGRIX.
Industry payments across MO — which companies pay providers there.
